Evogene Ltd. (EVGN)
EVGNNASDAQ-CMAgricultural Chemicals
$0.3830
+0.0110 (+2.96%) today
Regular session, Nov 11, 3:03 PM ET
- Market cap
- $6.06m
- P/E
- –
- EPS, last 4 quarters
- $-1.65
- Dividend yield
- –
- Day range
- $0.3300 to $0.4300
- 52-week range
- $0.2503 to $1.28
- Average volume
- 1.71m
- Previous close
- $0.3720
Earnings
next estimate $-0.1900Next report Nov 19, 2026
Sep 2025
–
Dec 2025
–
Mar 2026
–
Jun 2026
–
estimate reported, and the surprise
Financials
| Quarter | Dec 2012 | Dec 2013 |
|---|---|---|
| Revenue | $4.82m | $4.41m |
| Gross profit | $2.17m | $1.57m |
| Operating income | -$920.0k | -$4.04m |
| Net income | -$765.0k | -$4.22m |
News
8 latest- Evogene Targets Acute GVHD With AI-Driven Drug Discovery Program RTTNews · Oct 29, 2026
- Evogene Gets 180-day Nasdaq Extension To Regain Compliance RTTNews · Sep 30, 2026
- Evogene (EVGN) Q2 2026 Earnings Call TranscriptThe Motley Fool · Aug 25, 2026
- Evogene Q2 Loss Narrows As AI Transformation Drives Strategic Progress RTTNews · Aug 18, 2026
- Freightos Appoints Yaron Eldad As Chief Financial Officer RTTNews · Aug 17, 2026
- Evogene (EVGN) Price Target Increased by 28.57% to 2.30Fintel · Apr 28, 2026
- Evogene Licenses Microbiome-Based Cancer Therapeutic BMC128 To Shanghai Lishan Biopharmaceuticals RTTNews · Feb 4, 2026
- New Analyst Forecast: $EVGN Given $3.5 Price TargetQuiver Quantitative · May 23, 2025
The company
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for drug development and ag chemical products. At the core of its technology is ChemPass AITM, a proprietary generative AI designed to explore vast chemical space and generate novel, highly potent small molecules optimized across multiple critical parameters. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products for the pharmaceutical and agricultural industries, driven by the integration of scientific innovation with real-world industry needs.
- Sector
- Industrials
- Industry
- Agricultural Chemicals
- Exchange
- NASDAQ-CM
- Region
- Middle East
- Website
- evogene.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.